Skip to main content
. 2003 Jan;47(1):395–397. doi: 10.1128/AAC.47.1.395-397.2003

TABLE 1.

MICs of β-lactam antibiotics tested against VIM-1-producing and control E. coli strains

Antibiotic(s)a MIC (μg/ml) for E. coli strainb:
V541 wt 26R793 trc (VIM-1 + AmpC) 26R793 DH5α trf (VIM-1 + AmpC) DH5α (VIM-2) DH5α (LAT-1) DH5α
Ampicillin >256 >256 2 >256 >256 >256 1
Ticarcillin >256 >256 1 >256 >256 >256 0.5
Ticarcillin + CLA >256 >256 1 >256 >256 >256 1
Piperacillin >256 >256 1 >256 128 >256 0.5
Piperacillin + TAZ >256 >256 0.5 >256 128 64 0.25
Piperacillin + Ro >256 256 1 256 128 2 0.5
Cefoxitin >128 >128 2 >128 >128 >128 2
Cefoxitin + Ro >128 64 2 64 >128 2 2
Cefotaxime 128 >128 0.12 128 32 32 ≤0.06
Cefotaxime + Ro 128 128 ≤0.06 64 32 ≤0.06 ≤0.06
Cefazidime >128 >128 0.12 >128 64 128 0.12
Ceftazidime + Ro >128 >128 0.12 >128 64 0.5 0.12
Cefepime 64 32 ≤0.06 32 2 0.5 ≤0.06
Cefepime + Ro 64 32 ≤0.06 32 1 ≤0.06 ≤0.06
Aztreonam 8 4 ≤0.06 4 0.25 16 ≤0.06
Aztreonam + Ro 0.25 0.12 0.12 0.12 0.25 0.12 ≤0.06
Imipenem 8 8 ≤0.06 8 2 0.5 ≤0.06
Imipenem + Ro 8 8 ≤0.06 8 2 ≤0.06 ≤0.06
Meropenem 2 2 ≤0.06 1 1 0.12 ≤0.06
Meropenem + Ro 2 2 ≤0.06 1 1 ≤0.06 ≤0.06
a

CLA, clavulanic acid (2 μg/ml); TAZ, tazobactam (4 μg/ml); Ro, Ro 48-1220 (10 μg/ml).

b

wt, wild-type; trc, transconjugant; trf, transformant. The β-lactamas(es) produced by each strain is in parentheses.